Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine : A Case-Control Study.

Overview of attention for article published in ACP Journal Club, January 2022

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 55 news outlets
blogs: 3 blogs
policy: 1 policy source

twitter: 693 X users
facebook: 2 Facebook pages
reddit: 3 Redditors

Citations

dimensions_citation: 106 Dimensions

Readers on

mendeley: 71 Mendeley

Summary News Blogs Policy documents X Facebook Reddit Dimensions citations

So far, Altmetric has seen 4 posts from 3 blogs.

Myocarditis: Once Rare, Now Common

Climate Science, 05 Mar 2023

From Orthomolecular Medicine News…

Risk for Carditis Tied to Second Dose of Pfizer-BioNTech COVID-19 Vaccine

Physician's Weekly, 27 Jan 2022

THURSDAY, Jan. 27, 2022 (HealthDay News) — Despite a low absolute risk, there is an increased relative risk for carditis…

VAERS Data Confirm Myocarditis Risk After mRNA Vaccine

Physician's Weekly, 26 Jan 2022

A review of adverse events data in the United States from late 2020 through the summer of 2021 confirms that adolescent males…

A case-control study showed an increased risk of myocarditis after COVID-19 vaccination with a messenger RNA vaccine compared to an inactivated virus vaccine.

SPECIALTIES, 25 Jan 2022

Carditis After COVID-19 Vaccination With a Messenger RNA Vaccine and an Inactivated Virus Vaccine: A Case–Control Study …

This page shows the most recent blog posts that mention this research output.

Click here to find out how to access more activity.